• 1
    Heintz AP, Odicino F, Maisonneuve P, Beller U, Bendet J, Creasman W, et al. Carcinoma of the ovary. J Epidemiol Biostat 2001;6:10738.
  • 2
    FIGO committee on gynaecologic oncology. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynaecol Obstet 2009;105:1034.
  • 3
    Eitan R, Soslow R, Lin O, Kauff ND, Liu L, Barakat RR, et al. The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy. Gynecol Oncol 2006;102:3158.
  • 4
    Pavelka JC, Li AJ, Karlan BY. Hereditary ovarian cancer – assessing risk and prevention strategies. Obstet Gynecol Clin North Am 2007;34:6515.
  • 5
    Society of Gynecologic Oncologists. SGO clinical practice committee statement on prophylactic salpingo-oophorectomy. Gynecol Oncol 2005;98:17981.
  • 6
    Colgan TJ, Boerner SL, Murphy J, Cole DEC, Narod S, Rosen B. Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy. Gynecol Oncol 2002;85:397403.
  • 7
    Kauff ND, Satagopan JM. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:160915.
  • 8
    Carmon M, Olsha O, Levy-Lahad E, Zuckerman B, Rivkin L, Beller U. Laparoscopic oophorectomy combined with breast cancer surgery for breast cancer patients. Ann Cancer Res Therap 2006;24:1922.
  • 9
    Lynch HT, Lemon SJ, Durham C, Tinley ST, Connoly C, Lych JF. A descriptive study of BRCA1 testing and reaction to disclosure of test results. Cancer 1997;79:221928.
  • 10
    Reedy M, Gallion H, Fowler JM, Krysco R, Smith SA. Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynaecologic oncology group study. Gynecol Oncol 2002;85:2559.
  • 11
    Lu KH, Garber JE, Cramer DW, Welch WR, Niloff J, Schrag D, et al. Occult ovarian tumours in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol 2000;18:272832.
  • 12
    Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Komaromy M, et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in detection of occult malignancy. J Clin Oncol 2005;23:12732.
  • 13
    Ivazzo C, Kalmantis K, Ntziora F, Ioakimidis A, Paschalonopoulos D. The role of laboratory testing of free peritoneal fluid during an explorative laparotomy in the diagnosis of an extra-ovarian neoplasm. Bratisl Lek Listy 2007;108:30911.
  • 14
    Leunen K, Legius E, Moerman P, Amant F, Neven P, Vergote I. Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia. Int J Gynecol Cancer 2006;16:1838.
  • 15
    Sharifi S, Ducatman BS, Wang HH, Fraser JL. Peritoneal washing cytology is unnecessary in gynaecologic surgery for benign diseases. Cancer Cytopathol 1999;87:25962.
  • 16
    Mathew S, Erozan YS. Significance of peritoneal washings in gynaecologic oncology: the experience with 901 intra-operative washings at an academic medical centre. Arch Pathol Lab Med 1997;121:6046.